Check-Cap Investor Relations Material

Check-Cap Ltd. is a medical diagnostics company focused on the development of capsule-based screening technology aimed at detecting colorectal cancer in its early stages. The company's primary product is the C-Scan system, which utilizes a non-invasive, patient-friendly capsule that scans the inner lining of the colon using ultra-low-dose X-rays. This system generates detailed 3D maps of the colon's contours, allowing physicians to identify precancerous polyps and other abnormalities without the need for traditional bowel preparation or invasive procedures. The technology aims to improve patient compliance with colorectal cancer screening protocols globally. The company is headquartered in Isfiya, Israel, and its shares are listed on the NASDAQ.